Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary product categories, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. It supports customers spanning the life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and others, with catalog and custom, made-to-order products.
Growing
The company is in a growing phase, with the latest annual income totaling USD 40.52M.
Undervalued
The company’s latest PE is -18.05, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 45.71M shares, decreasing 3.80% quarter-over-quarter.
Held by ETHSX
Star Investor ETHSX holds 43.47K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of -0.14.